spacer
home > pmps > winter 2001 > medical and pharmaceutical translation - the need for a specialist
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Medical and Pharmaceutical Translation - The Need for a Specialist

The globalisation of business has led to the need for the medical and pharmaceutical industries to simultaneously satisfy the requirements of regulatory authorities, including submission of information in a variety of languages. For example, those pharmaceutical companies submitting a marketing authorisation application in order to fulfil EU dossier requirements must provide a summary of product characteristics (Part IB), labelling information and a patient information leaflet in every official EU language. In addition, there are often layout requirements and the need to use phrase constructions that are fixed and mandatory. Finally, similar requirements also apply to CE Marking related documentation for the medical devices market. Only a professional and specialised company can provide the expertise needed for this sort of demanding translation work.

To work as a translator, a person must not only be fluent in multiple languages, but also have the academic foundation upon which to base a thorough understanding of the current status and terminology of highly specialised areas of business, law, technology, economy and health care. The translator must have a solid linguistic education.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Arthur P. Leccese of Wilkens c.s. in the Netherlands Dr Arthur P. Leccese holds a PhD in Physiological Psychology. For two decades, he conducted research and taught courses in psychopharmacology in the US After working with several pharmaceutical firms in the Netherlands, he joined Wilkens c.s. as a Translator of medical-pharmaceutical texts.
spacer
Arthur P. Leccese
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) a subsidiary of WuXi AppTec and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement